{"pmid":32291365,"title":"Diagnosing COVID-19: Did We Miss Anything?","text":["Diagnosing COVID-19: Did We Miss Anything?","In late 2019, a mass of patients showing symptoms of a pneumonia-like disease of unknown origin emerged in Wuhan, China. Little did the world know it was the prelude of what would be a devastating pandemic. Samples were collected from these patients and the use of unbiased sequencing, and subsequent isolation of the pathogen using human airway epithelial cells led to the discovery of a novel coronavirus, named 2019-nCoV by the World Health Organization (WHO) and Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. The disease caused by this virus is officially called the coronavirus disease 2019 (COVID-19).","Acta Med Indones","Tenda, Eric Daniel","Asaf, Moses Mazmur","32291365"],"abstract":["In late 2019, a mass of patients showing symptoms of a pneumonia-like disease of unknown origin emerged in Wuhan, China. Little did the world know it was the prelude of what would be a devastating pandemic. Samples were collected from these patients and the use of unbiased sequencing, and subsequent isolation of the pathogen using human airway epithelial cells led to the discovery of a novel coronavirus, named 2019-nCoV by the World Health Organization (WHO) and Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. The disease caused by this virus is officially called the coronavirus disease 2019 (COVID-19)."],"journal":"Acta Med Indones","authors":["Tenda, Eric Daniel","Asaf, Moses Mazmur"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32291365","week":"202016|Apr 13 - Apr 19","keywords":["Internal Medicine","Respirology"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664266295557750784,"score":8.233237,"similar":[{"pmid":31978945,"pmcid":"PMC7092803","title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019.","text":["A Novel Coronavirus from Patients with Pneumonia in China, 2019.","In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia. Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily. Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans. Enhanced surveillance and further investigation are ongoing. (Funded by the National Key Research and Development Program of China and the National Major Project for Control and Prevention of Infectious Disease in China.).","N Engl J Med","Zhu, Na","Zhang, Dingyu","Wang, Wenling","Li, Xingwang","Yang, Bo","Song, Jingdong","Zhao, Xiang","Huang, Baoying","Shi, Weifeng","Lu, Roujian","Niu, Peihua","Zhan, Faxian","Ma, Xuejun","Wang, Dayan","Xu, Wenbo","Wu, Guizhen","Gao, George F","Tan, Wenjie","31978945"],"abstract":["In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia. Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily. Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans. Enhanced surveillance and further investigation are ongoing. (Funded by the National Key Research and Development Program of China and the National Major Project for Control and Prevention of Infectious Disease in China.)."],"journal":"N Engl J Med","authors":["Zhu, Na","Zhang, Dingyu","Wang, Wenling","Li, Xingwang","Yang, Bo","Song, Jingdong","Zhao, Xiang","Huang, Baoying","Shi, Weifeng","Lu, Roujian","Niu, Peihua","Zhan, Faxian","Ma, Xuejun","Wang, Dayan","Xu, Wenbo","Wu, Guizhen","Gao, George F","Tan, Wenjie"],"date":"2020-01-25T11:00:00Z","year":2020,"_id":"31978945","week":"20204|Jan 20 - Jan 26","doi":"10.1056/NEJMoa2001017","link_comment_in":"32162476","source":"PubMed","locations":["Wuhan","China","Pneumonia"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1663352134873120769,"score":216.95694},{"pmid":32239515,"title":"Fecal Transmission in COVID-19: A Potential Shedding Rout.","text":["Fecal Transmission in COVID-19: A Potential Shedding Rout.","We read with interest recent article by Zhang et al (1) on the diagnosis of Coronavirus disease 2019 (COVID-19) by fecal specimen test. Following the recent outbreak of pneumonia with unknown pathogen in Hubei province in China, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolated from human airway epithelial cells and the disease was named COVID-19.(2) It is a public health emergency of international concern and rapidly spearing all over the world.(3) This article is protected by copyright. All rights reserved.","J Med Virol","Nouri-Vaskeh, Masoud","Alizadeh, Leila","32239515"],"abstract":["We read with interest recent article by Zhang et al (1) on the diagnosis of Coronavirus disease 2019 (COVID-19) by fecal specimen test. Following the recent outbreak of pneumonia with unknown pathogen in Hubei province in China, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolated from human airway epithelial cells and the disease was named COVID-19.(2) It is a public health emergency of international concern and rapidly spearing all over the world.(3) This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Nouri-Vaskeh, Masoud","Alizadeh, Leila"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32239515","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25816","source":"PubMed","locations":["China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission"],"weight":1,"_version_":1663352135445643264,"score":188.76717},{"pmid":32172672,"pmcid":"PMC7103735","title":"A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.","text":["A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.","World Health Organization has declared the ongoing outbreak of coronavirus disease 2019 (COVID-19) a Public Health Emergency of International Concern. The virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. Human infection with SARS-CoV-2 leads to a wide range of clinical manifestations ranging from asymptomatic, mild, moderate to severe. The severe cases present with pneumonia, which can progress to acute respiratory distress syndrome. The outbreak provides an opportunity for real-time tracking of an animal coronavirus that has just crossed species barrier to infect humans. The outcome of SARS-CoV-2 infection is largely determined by virus-host interaction. Here, we review the discovery, zoonotic origin, animal hosts, transmissibility and pathogenicity of SARS-CoV-2 in relation to its interplay with host antiviral defense. A comparison with SARS-CoV, Middle East respiratory syndrome coronavirus, community-acquired human coronaviruses and other pathogenic viruses including human immunodeficiency viruses is made. We summarize current understanding of the induction of a proinflammatory cytokine storm by other highly pathogenic human coronaviruses, their adaptation to humans and their usurpation of the cell death programmes. Important questions concerning the interaction between SARS-CoV-2 and host antiviral defence, including asymptomatic and presymptomatic virus shedding, are also discussed.","Emerg Microbes Infect","Fung, Sin-Yee","Yuen, Kit-San","Ye, Zi-Wei","Chan, Chi-Ping","Jin, Dong-Yan","32172672"],"abstract":["World Health Organization has declared the ongoing outbreak of coronavirus disease 2019 (COVID-19) a Public Health Emergency of International Concern. The virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. Human infection with SARS-CoV-2 leads to a wide range of clinical manifestations ranging from asymptomatic, mild, moderate to severe. The severe cases present with pneumonia, which can progress to acute respiratory distress syndrome. The outbreak provides an opportunity for real-time tracking of an animal coronavirus that has just crossed species barrier to infect humans. The outcome of SARS-CoV-2 infection is largely determined by virus-host interaction. Here, we review the discovery, zoonotic origin, animal hosts, transmissibility and pathogenicity of SARS-CoV-2 in relation to its interplay with host antiviral defense. A comparison with SARS-CoV, Middle East respiratory syndrome coronavirus, community-acquired human coronaviruses and other pathogenic viruses including human immunodeficiency viruses is made. We summarize current understanding of the induction of a proinflammatory cytokine storm by other highly pathogenic human coronaviruses, their adaptation to humans and their usurpation of the cell death programmes. Important questions concerning the interaction between SARS-CoV-2 and host antiviral defence, including asymptomatic and presymptomatic virus shedding, are also discussed."],"journal":"Emerg Microbes Infect","authors":["Fung, Sin-Yee","Yuen, Kit-San","Ye, Zi-Wei","Chan, Chi-Ping","Jin, Dong-Yan"],"date":"2020-03-17T11:00:00Z","year":2020,"_id":"32172672","week":"202012|Mar 16 - Mar 22","doi":"10.1080/22221751.2020.1736644","keywords":["*2019 novel coronavirus","*COVID-19","*Coronavirus","*SARS-CoV","*SARS-CoV-2","*host antiviral response","*type I interferon"],"source":"PubMed","topics":["Mechanism","Transmission"],"weight":1,"_version_":1663352133924159488,"score":175.67972},{"pmid":32174267,"title":"Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned.","text":["Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned.","Unexplained pneumonia (UP) caused by a novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) emerged in China in late December 2019 and has infected more than 9000 cases by 31 January 2020. Shanghai reported the first imported case of COVID-19 (Coronavirus Disease 2019) in 20 January 2020. A combinative approach of real-time RT-PCR, CRISPR-based assay and metagenomic next-generation sequencing (mNGS) were used to diagnose this unexplained pneumonia patient. Real-time RT-PCR and CRISPR-based assay both reported positive. This sample belonged to Betacoronavirus and shared a more than 99% nucleotide (nt) identity with the Wuhan SARS-CoV-2 isolates. We further compared pros and cons of common molecular diagnostics in UP. In this study, we illustrated the importance of combining molecular diagnostics to rule out common pathogens and performed mNGS to obtain unbiased potential pathogen result for the diagnosis of UP.","Emerg Microbes Infect","Ai, Jing-Wen","Zhang, Yi","Zhang, Hao-Cheng","Xu, Teng","Zhang, Wen-Hong","32174267"],"abstract":["Unexplained pneumonia (UP) caused by a novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) emerged in China in late December 2019 and has infected more than 9000 cases by 31 January 2020. Shanghai reported the first imported case of COVID-19 (Coronavirus Disease 2019) in 20 January 2020. A combinative approach of real-time RT-PCR, CRISPR-based assay and metagenomic next-generation sequencing (mNGS) were used to diagnose this unexplained pneumonia patient. Real-time RT-PCR and CRISPR-based assay both reported positive. This sample belonged to Betacoronavirus and shared a more than 99% nucleotide (nt) identity with the Wuhan SARS-CoV-2 isolates. We further compared pros and cons of common molecular diagnostics in UP. In this study, we illustrated the importance of combining molecular diagnostics to rule out common pathogens and performed mNGS to obtain unbiased potential pathogen result for the diagnosis of UP."],"journal":"Emerg Microbes Infect","authors":["Ai, Jing-Wen","Zhang, Yi","Zhang, Hao-Cheng","Xu, Teng","Zhang, Wen-Hong"],"date":"2020-03-17T11:00:00Z","year":2020,"_id":"32174267","week":"202012|Mar 16 - Mar 22","doi":"10.1080/22221751.2020.1738905","keywords":["*COVID-19","*SARS-CoV-2","*Unexplained pneumonia","*diagnosis","*molecular"],"source":"PubMed","locations":["UP","Shanghai","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1663352133898993664,"score":171.10847},{"pmid":32259829,"title":"COVID-19 Outbreak: An Overview.","text":["COVID-19 Outbreak: An Overview.","BACKGROUND: In late December 2019, Chinese health authorities reported an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province. SUMMARY: A few days later, the genome of a novel coronavirus was released (http://viro-logical.org/t/novel-2019-coronavirus-genome/319; Wuhan-Hu-1, GenBank accession No. MN908947) and made publicly available to the scientific community. This novel coronavirus was provisionally named 2019-nCoV, now SARS-CoV-2 according to the Coronavirus Study Group of the International Committee on Taxonomy of Viruses. SARS-CoV-2 belongs to the Coronaviridae family, Betacoronavirus genus, subgenus Sarbecovirus. Since its discovery, the virus has spread globally, causing thousands of deaths and having an enormous impact on our health systems and economies. In this review, we summarize the current knowledge about the epidemiology, phylogenesis, homology modeling, and molecular diagnostics of SARS-CoV-2. Key Messages: Phylogenetic analysis is essential to understand viral evolution, whereas homology modeling is important for vaccine strategies and therapies. Highly sensitive and specific diagnostic assays are key to case identification, contact tracing, identification of the animal source, and implementation of control measures.","Chemotherapy","Ciotti, Marco","Angeletti, Silvia","Minieri, Marilena","Giovannetti, Marta","Benvenuto, Domenico","Pascarella, Stefano","Sagnelli, Caterina","Bianchi, Martina","Bernardini, Sergio","Ciccozzi, Massimo","32259829"],"abstract":["BACKGROUND: In late December 2019, Chinese health authorities reported an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province. SUMMARY: A few days later, the genome of a novel coronavirus was released (http://viro-logical.org/t/novel-2019-coronavirus-genome/319; Wuhan-Hu-1, GenBank accession No. MN908947) and made publicly available to the scientific community. This novel coronavirus was provisionally named 2019-nCoV, now SARS-CoV-2 according to the Coronavirus Study Group of the International Committee on Taxonomy of Viruses. SARS-CoV-2 belongs to the Coronaviridae family, Betacoronavirus genus, subgenus Sarbecovirus. Since its discovery, the virus has spread globally, causing thousands of deaths and having an enormous impact on our health systems and economies. In this review, we summarize the current knowledge about the epidemiology, phylogenesis, homology modeling, and molecular diagnostics of SARS-CoV-2. Key Messages: Phylogenetic analysis is essential to understand viral evolution, whereas homology modeling is important for vaccine strategies and therapies. Highly sensitive and specific diagnostic assays are key to case identification, contact tracing, identification of the animal source, and implementation of control measures."],"journal":"Chemotherapy","authors":["Ciotti, Marco","Angeletti, Silvia","Minieri, Marilena","Giovannetti, Marta","Benvenuto, Domenico","Pascarella, Stefano","Sagnelli, Caterina","Bianchi, Martina","Bernardini, Sergio","Ciccozzi, Massimo"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259829","week":"202015|Apr 06 - Apr 12","doi":"10.1159/000507423","keywords":["COVID-19","Pandemic","Phylogenesis","Protein modeling","Real-time polymerase chain reaction","SARS-CoV-2"],"source":"PubMed","locations":["Wuhan","Hubei","Sarbecovirus","Wuhan-Hu-1","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1663450393427836928,"score":164.71902}]}